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ABSTRACT 
Objectives. Vancomycin resistance among enterococci represents an important medical challenge. 
This phenotype is frequently associated to the expression of the vanA trait and is usually observed 
in Enterococcus faecalis/faecium. In contrast, the VanA phenotype has been very rarely reported in 
Enterococcus avium. VanA mobilization is enabled mainly by transposition of Tn1546 which 
displays structural variability. Here, we aimed to explore in detail the whole-genome of a 
vancomycin-resistant E. avium isolate (LC0559/18). 
Methods. LC0559/18 was recovered from a rectal swab of an ICU-patient hospitalized in Northern 
Italy. Vancomycin-resistant enterococci were searched with selective plates. Species identification 
and antimicrobial resistance profile were assessed by MALDI-TOF/MS and VITEK2, respectively. 
Whole-genome sequencing (WGS) was obtained merging data of both HiSeq (Illumina) and 
MinION (Oxford Nanopore) platforms. 
Results. LC0559/18 showed MICs >16 mg/L and 16 mg/L for vancomycin and teicoplanin, 
respectively. WGS analysis indicated the presence of two plasmids. pLC0559/18-1 (40’456bp) was 
of replicon type rep17 and harbored vanA, aph(3’)III, ant(6)-Ia antimicrobial resistance genes 
(ARGs). The vanA cassette was on a Tn1546-B2 variant reported to date only in E. faecium. This 
variant includes presence of element IS1216, as well as absence of transposase ORF1 and resolvase 
ORF2 of the native Tn1546. Moreover, Tn1546-B2 of LC0559/18 was carried by a novel plasmid 
backbone. pLC0559/18-2 (52’156bp) was repUS7 positive and did not harbor ARGs.  
Conclusions. We report a new plasmid backbone of rarely reported vancomycin-resistant E. avium 
and provide detailed characteristics of its vanA genetic environment. In turn, this highlights further 
mobilization of Tn1546 among this genus.  
 
KEY WORDS: vancomycin, WGS, VanA, Enterococcus avium, Tn1546, plasmid  
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Sir, 
Since the first isolation (1986), vancomycin-resistant enterococci (VRE) have been increasingly 
reported representing nowadays a global public health concern. This is mainly due to their ongoing 
spread in nosocomial settings along with scarce number of available effective antimicrobials [1, 2]. 
Among the eight types responsible for acquired vancomycin resistance, the VanA phenotype 
(defined by high-level vancomycin and teicoplanin resistance) is the best characterized and it counts 
for most of glycopeptide resistance dissemination in clinical settings [1, 3]. 
The main indicted for the ongoing spread of vancomycin resistance in clinical isolates of 
Enterococcus spp. is the plastic antimicrobial resistance transposon Tn1546 (a 10’851bp derivative 
of Tn3, originally described in E. faecium). This element is able to easily transpose into diverse 
conjugative plasmid’s backbones and it carries the vanA operon responsible for the resistance 
phenotype [3, 4]. Tn1546 also shows a typical high degree of heterogeneity illustrated by tens of 
mutational derivatives of the A1 transposon prototype. These are distinguished by numerous point 
mutations, deletions, as well as insertion sequences (ISs) (e.g., IS1216) in different positions and 
orientations, likely acquired by independent events of recombination [1]. However, though 
frequently described in E. faecium and E. faecalis, the vanA determinant has been rarely described 
in E. avium (Suppl. Table 1). In particular, only one 80kb plasmid carrying a Tn1546 has been 
deposited so far [5]. 
In this work, we describe the first whole-genome of an E. avium clinical isolate of VanA phenotype 
harboring a novel plasmid backbone and carrying a variant of Tn1546 previously reported only in 
E. faecium. 
The isolate (LC0559/18) was recovered from a 26-year-old male patient hospitalized at the 
intensive care unit (ICU) of the A. Manzoni Hospital (Lecco, Italy) on February 2018 for a distress 
respiratory syndrome. The patient came from a neurological rehabilitation unit and was already in 
treatment with ceftriaxone (1 g b.i.d.). On ICU admission, therapy was switched to meropenem (2 g 
t.i.d.), vancomycin (2 g q.d.), and oseltamivir (150 mg loading dose, then 75 mg b.i.d.) for a 9-day 
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period. Five days after admission, the patient was investigated by a rectal swab for the presence of 
VRE within a routine screening program. Culture on selective plates (CHROMID VRE, 
bioMérieux) was positive for enterococci able to grow in presence of vancomycin. MALDI-
TOF/MS (Vitek MS; bioMérieux) allowed identification of E. avium. Resistance phenotype was 
assessed by using the VITEK2 (bioMérieux) and revealed the following antibiotic phenotype 
(MICs, mg/L): ampicillin (≤2 mg/L), levofloxacin (0.25 mg/L), vancomycin (>16 mg/L), 
teicoplanin (16 mg/L), and linezolid (2 mg/L) (EUCAST, version 8.0, 2018).  
Hybrid assembly of whole-genome sequencing (WGS) was obtained merging data of both 
HiSeq (Illumina Inc.) and MinION (Oxford Nanopore) platforms. Briefly, MinION reads underwent 
trimming with Porechop and filtering with Filtlong software followed by assembly and contig’s 
circularization by mean of CANU and Circlator pipelines, respectively. Adapters of HiSeq reads 
were trimmed implementing Trimmomatic, and then further aligned to assemble MinION’s contigs 
using Bowtie2 aligner. Final genome polishing and annotation were performed using Pilon and 
Prokka software. Corrected FASTA sequences (GenBank accession no. RYZS00000000) were 
uploaded on online database Center for Genomic Epidemiology (www.genomicepidemiology.org/) 
to obtain data on resistance genes, major plasmid’s replicon types, and virulence factors. Species 
identity was confirmed by nucleotide comparison with 16S ribosomal RNA gene of E. avium strain 
ATCC14025 (GenBank accession no. DQ411811). 
WGS analysis indicated that LC0559/18 carried two plasmids (pLC0559/18-1 of 40’456bp and 
pLC0559/18-2 of 52’156bp). pLC0559/18-1 was of replicon type rep17, harbored vanA (on 
transposon Tn1546-B2-type), aph(3’)III, and ant(6)-Ia antimicrobial resistance genes (ARGs), 
while pLC0559/18-2 was of replicon type repUS7 and did not carry ARGs. Virulence factors were 
not present. 
Local alignment of complete sequence of pLC0559/18-1 with NCBI Blast indicated that 
pLC0559/18-1 was a novel plasmid. However, the genetic environment of vanA, spanning from 
1’909bp to 10’041bp (Figure 1), showed 99% nucleotide identity with 20 deposited sequences of E. 
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faecium, 9 of which covering up to 17kb of its sequence. Part of this region constitutes a variant of 
the widely reported transposon Tn1546-B2-type whose characteristics are the presence of 
transposase IS1216 (belonging to IS6 family) upstream and in opposite orientation with respect to 
vanR, as also the consequent absence of transposase ORF1 and resolvase ORF2 [1, 3].  The present 
transposon variant (reported to date only in E. faecium) is characterized by an additional IS1215-
like element inserted upstream of vanS (Figure 1). The two further additional resistance genes 
aph(3’)III and ant(6)-Ia were located 1’246bp and 3’146bp upstream of the accessory gene vanR, 
respectively. 
The present report exposes detailed characteristics of the vanA gene cassette in rarely 
reported vancomycin-resistant E. avium, thereby highlighting variability of Tn1546 as also its host 
range’s expansion for the VanA phenotype. Moreover, it implicates presence of an emerging and 
additional bacterial player in the dissemination and evolution of vancomycin resistance in the 
nosocomial setting [1, 3]. 
 
 
 
ACKNOWLEDGMENTS 
None 
 
DECLARATIONS 
Funding: This work was supported by using internal funds of the Institute for Infectious Diseases.  
Competing Interests: None 
Ethical Approval: Not required  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
6 
 
REFERENCES  
[1] Wardal E, Kuch A, Gawryszewska I, Zabicka D, Hryniewicz W, Sadowy E. Diversity of 
plasmids and Tn1546-type transposons among VanA Enterococcus faecium in Poland. Eur J Clin 
Microbiol Infect Dis. 2017;36:313-28. 
[2] Levitus M, Perera TB. Vancomycin-Resistant Enterococci (VRE).  StatPearls. Treasure Island 
(FL)2018. 
[3] Novais C, Freitas AR, Sousa JC, Baquero F, Coque TM, Peixe LV. Diversity of Tn1546 and its 
role in the dissemination of vancomycin-resistant enterococci in Portugal. Antimicrob Agents 
Chemother. 2008;52:1001-8. 
[4] Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. 
Antimicrob Agents Chemother. 1993;37:1563-71. 
[5] Sun L, Zhang P, Qu T, Chen Y, Hua X, Shi K, et al. Identification of Novel Conjugative 
Plasmids with Multiple Copies of fosB that Confer High-Level Fosfomycin Resistance to 
Vancomycin-Resistant Enterococci. Front Microbiol. 2017;8:1541. 
 
  
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
7 
 
LEGEND TO THE FIGURE 
 
 
 
Figure 1: Schematic representation of native and B2-type Tn1546 in pLC055/18-1 and in three 
other deposited plasmids of E. faecium 
Numbers indicate starts and ends of depicted genes and are expressed in bp. Arrows indicate 
directions of the open reading frames (ORFs). ORFs: ORF1, transposase; ORF2, resolvase; IS1216, 
transposase; VanR, response regulator; VanS, sensor histidine kinase; CDS, IS1215-like transposase; 
VanH, pyruvate dehydrogenase; VanA, D-Ala-d-Lac ligase; VanX, D-Ala-d-Ala dipeptidase; VanY, 
carboxypeptidase; VanZ, teicoplanin resistant protein.  
A. Enterococcus faecium strain BM4147 plasmid pIP816; accession no. KX976485 (deposited on 
12.09.2017; France) 
B. Enterococcus avium strain LC 0559/18 plasmid pLC0559/18-1; present work (GenBank 
accession no. RYZS00000000). 
C. Enterococcus faecium strain VREfm1 plasmid pPEC286; accession no. KY595962.1 (deposited 
on 24.5.2018; Hungary). 
D. Enterococcus faecium strain ISMMS_VRE_10 plasmid ISMMS_VRE10_p3; accession no. 
CP012474.1 (deposited on 22.03.2017; USA). 
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E. Enterococcus faecium strain Efm008 plasmid pJEG040; accession no. KX810025.1 (deposited 
on 19.11.16; Australia). 
 
